PFIZER/BIONTECH ANNOUNCE NEW SARS-CoV-2 Injection

PFIZER/BIONTECH ANNOUNCEMENT

An article in Fierce Biotech, January 25 2022, titled Pfizer, BioNTech launch trial for potential omicron-busting vaccine, announced that Pfizer and BioNTech are launching a new clinical trial to test a potential omicron-busting COVID-19 vaccine.

The press release, Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age is shown here.

IMPORTANT SAFETY INFORMATION

Included in the press release is some very helpful information:

Individuals should not get the vaccine if they:

• had a severe allergic reaction after a previous dose of this vaccine

• had a severe allergic reaction to any ingredient of this vaccine

Individuals should tell the vaccination provider about all of their medical conditions, including if they:

• have any allergies

• have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the lining outside the heart)

• have a fever

• have a bleeding disorder or are on a blood thinner

• are immu…